AGMO and diabetes mellitus: Focusing on PaC cases and controls without diabetes, we identified DGKB-TMEM195 rs2191348 (OR = 1.23, 95% CI 1.03–1.47, p = 0.02), KCNQ1 rs231362 (OR = 1.24, 95% CI 1.00–1.53, p = 0.046), ADCY5 rs2877716 (OR = 1.28, 95% CI 1.05–1.58, p = 0.02) and BCL11A rs243021 (OR = 0.83, 95% CI 0.69–0.99, p = 0.04) (Table 2).